Advanced Filter

Filter by Group

Filter by Market Availability

Displaying all 2 drugs
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type 2 diabetes mellitus (T2DM). It is sold under the brand name Adlyxin by Sanofi-Aventis. Adlyxin recieved FDA approval July 28, 2016 .
Approved
Matched Synonyms: … Lixisenatide
Matched Name: … Lixisenatide
Matched Description: … Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type 2 diabetes …
Matched Categories: … insulin glargine and lixisenatide ... lixisenatide ... Alimentary Tract and Metabolism ... Amino Acids, Peptides, and Proteins …
Insulin glargine is a long-acting form of insulin used for the treatment of hyperglycemia caused by Type 1 and Type 2 Diabetes. Insulin is typically prescribed for the management of diabetes mellitus to mimic the activity of endogenously produced human insulin, a peptide hormone produced by beta cells of the...
Approved
Matched Synonyms: … Insulin glargine ... Insulin glargine recombinant ... Insulin Glargine (rDNA origin) …
Matched Name: … Insulin glargine
Matched Description: … Insulin glargine is also available as the biosimilar, or "follow-on" product, Basaglar in the US and ... Insulin glargine is a long-acting form of insulin used for the treatment of hyperglycemia caused by Type ... As a result, people with T1D rely primarily on exogenous forms of insulin, such as insulin glargine, …
Matched Categories: … insulin glargine and lixisenatide ... insulin glargine ... Alimentary Tract and Metabolism ... Insulin ... Amino Acids, Peptides, and Proteins …
Displaying all 2 drugs